Abstract
Traumatic brain injury (TBI) is a risk factor for neurodegeneration and cognitive decline, yet the underlying pathophysiologic mechanisms are incompletely understood. This gap in knowledge is in part related to a lack of reliable and efficient methods for measuring cortical lesions in neuroimaging studies. The objective of this study was to develop a semi-automated lesion detection tool and apply it to an investigation of longitudinal changes in brain structure among individuals with chronic TBI. We identified 24 individuals with chronic moderate-to-severe TBI enrolled in the Late Effects of TBI (LETBI) study who had cortical lesions detected by T1-weighted MRI and underwent two MRI scans at least two years apart. Initial MRI scans were performed more than one year post-injury, and follow-up scans were performed 3.1 (IQR=1.7) years later. We leveraged FreeSurfer parcellations of T1-weighted MRI volumes and a recently developed super-resolution technique, SynthSR, to automate the identification of cortical lesions in this longitudinal dataset. Trained raters received the data in a randomized order and manually edited the automated lesion segmentations, yielding a final semi-automated lesion mask for each scan at each time point. Inter-rater variability was assessed in an independent cohort of 10 additional LETBI subjects with cortical lesions. The semi-automated lesion segmentations showed a high level of accuracy compared to “ground truth” lesion segmentations performed via manual segmentation by a separate blinded rater. In a longitudinal analysis of the semi-automated segmentations, lesion volume increased between the two time points with a median volume change of 4.91 (IQR=12.95) mL (p<0.0001). Lesion volume significantly expanded in 40 of 61 measured lesions (65.6%), as defined by a longitudinal volume increase that exceeded inter-rater variability. Longitudinal analyses showed similar changes in lesion volume using the ground-truth lesion segmentations. Inter-scan duration was not associated with the magnitude of lesion growth. Reliable and efficient semi-automated lesion segmentation is feasible in studies of chronic TBI, creating opportunities to elucidate mechanisms of post-traumatic neurodegeneration.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the NIH National Institute of Neurological Disorders and Stroke (RF1NS128961R01NS128961 RF1NS115268 U01NS086625), NIH Directors Office (DP2HD101400), and the Chen Institute MGH Research Scholar Award.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Boards at Mount Sinai School of Medicine and University of Washington School of Medicine.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* co-senior authors
Funding: This study was supported by the NIH National Institute of Neurological Disorders and Stroke (RF1NS128961R01NS128961, RF1NS115268, U01NS086625), NIH Director’s Office (DP2HD101400), and the Chen Institute MGH Research Scholar Award.
Declarations: Ethics approval This study was approved by the Institutional Review Boards at Mount Sinai School of Medicine and University of Washington School of Medicine.
Informed consent Informed consent was provided by participants or their surrogates, if participants lacked decision-making capacity.
Conflicts of interests None
Updated statistical methods and figures. Clarified techniques and implications.
Data Availability
Data are available upon reasonable request to the authors.
